Artesunate-loaded chitosan/lecithin nanoparticles: Preparation, characterization, and in vivo studies

Drug Development and Industrial Pharmacy

Volumn 38, Issue 12, 2012, Pages 1538-1546

  Chadha, Renu ^a   Gupta, Sushma ^a   Pathak, Natasha ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

cyclodextrin; Artesunate; entrapment efficiency; in vivo antimalarial activity; nanospheres

Indexed keywords

ARTESUNATE; BETA CYCLODEXTRIN; CHITOSAN; PHOSPHATIDYLCHOLINE;

ANTIMALARIAL ACTIVITY; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DECOMPOSITION; DRUG FORMULATION; DRUG RELEASE; HUMAN; IN VIVO STUDY; PARTICLE SIZE; PH; THERMOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BETA-CYCLODEXTRINS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; CHITOSAN; DRUG COMPOUNDING; LECITHINS; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; PLASMODIUM BERGHEI; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 84868351262     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.658812     Document Type: Article

References (21)

1. Klayman DL. (1985). Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228:1049-1055. (Pubitemid 15227365)
2. World Health Organization. (2000). Trans. R. Soc Trop Med Hyg, 94 (1), 36.
3. Augustijns P, D'Hulst A, Van Daele J, Kinget R. (1996). Transport of artemisinin and sodium artesunate in Caco-2 intestinal epithelial cells. J Pharm Sci, 85:577-579. (Pubitemid 26179652)
4. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW et al. (1999). Averting a malaria disaster. Lancet, 353:1965-1967. (Pubitemid 29255721)
5. Akinlolu AA, Shokunbi MT. (2010). Neurotoxic effects of 25mg/kg/bodyweight of artemether on the histology of the trapezoid nuclei and behavioural functions in adult male Wistar rats. Acta Histochem, 112:193-198.
6. Titulaer HAC, Zuidema J, Lugt CB. (1991). Formulation and pharmacokinetics of arthemisinin and its derivatives. Int J Pharm, 69, 83-92.
7. Leite EA, Grabe-Guimarães A, Guimarães HN, Machado-Coelho GL, Barratt G, Mosqueira VC. (2007). Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci, 80:1327-1334.
8. Song M, Li Y, Fai C, Cui S, Cui B. (2011). The controlled release of tilmicosin from silica nanoparticles. Drug Dev Ind Pharm, 37:714-718.
9. da Silva Santos NP, Nascimento SC, Wanderley MS, Pontes-Filho NT, da Silva JF, de Castro CM et al. (2006). Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity. Eur J Pharm Biopharm, 64:154-160. (Pubitemid 44291998)
10. Legrand P, Barratt G, Mosqueira V, Fessi H, Devissaguet JP. (1999). Polymeric nanocapsules as drug delivery systems: a review. S T P Pharm Sci, 9, 411-418.
11. Mosqueira VC, Legrand P, Morgat JL, Vert M, Mysiakine E, Gref R et al. (2001). Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res, 18:1411-1419. (Pubitemid 32977246)
12. Yue-Jian C, Juan T, Fei X, Jia-Bi Z, Ning G, Yi-Hua Z et al. (2010). Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm, 36:1235-1244.
13. Xiao XC, Hong ZG. (2010). Firstborn microcrystallization method to prepare nanocapsules containing artesunate. Int J Nanomedicine, 5:483-486.
14. Hartell MG, Hicks R, Bhattacharjee AK, Koser BW, Carvalho K, Van Hamont JE. (2004). Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with beta-cyclodextrin. J Pharm Sci, 93:2076-2089. (Pubitemid 39045488)
15. Gabriëls M, Plaizier-Vercammen J. (2003). Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal, 31:655-667. (Pubitemid 36315707)
16. Zhao KC, Xuan WY, Zhao Y, Song ZY. (1989). [The pharmacokinetics of a transdermal preparation of artesunate in mice and rabbits]. Yao Xue Xue Bao, 24:813-816.
17. Sonvico F, Cagnani A, Rossi A, Motta S, Di Bari MT, Cavatorta F et al. (2006). Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm, 324:67-73. (Pubitemid 44548291)
18. Chadha R, Gupta S, Shukla G, Jain DVS, Pissurlenkar RRS, Coutinho EC. (2011) Interaction of artesunate with b-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity. Results in Pharma Sciences, 1, 38-48.
19. Shufang N, Shu Z, Weisan P, Yanli L. (2011) In vitro and in vivo studies on the complexes of glipizide with water soluble β-cyclodextrin- epichlorohydrin polymers. Drug Development and Industrial Pharmacy, 37(5), 606-612.
20. Magenheim B, Levy MY, Benita S. (1993). A new in vitro technique for the evaluation of drug release profile from colloidal carriers-ultra filtration technique at low pressure. Int J Pharm, 94, 115-123. (Pubitemid 23204057)
21. Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. (2009). Melatoninloaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm, 381:205-213.